Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Streck MDx-Chex™ for Blood Culture - Gram-Negative (BC-GN)
SDP

MDx-Chex for BC-GP and MDx-Chex for BC-GN are controls designed to evaluate the entire analytical process of the Luminex VERIGENE™ BC-GP and BC-GN Panels for sepsis. With MDx-Chex for BC-GP and MDx-Chex for BC-GN, you can track lot-to-lot performance of the BC-GP and BC-GN assays and reduce the occurrence of incorrect results due to instrument or assay failures.

Supplier:  Streck 250080

Catalog No. 23-285-983


missing translation for 'QuantityLeft'
Explore all special offers
Add to Cart
This item is not returnable. View return policy

Description

Description

  • Patient-like matrix of inactivated microorganisms, blood cells and culture media components.
  • Can be directly used on the Luminex VERIGENE system.
  • Complete coverage of all BC-GP or BC-GN Panel targets in a single vial.
  • Negative controls contain only blood cells and culture media components for a true patient-like negative control.
  • Challenges and verifies the entire analytical process of the Luminex VERIGENE assays.
  • Reduces preanalytical variables such as pipetting errors and cross-contamination.
Specifications

Specifications

Quality Control
5 Positive Controls, 5 Negative Controls
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.